Current Report Filing (8-k)
April 09 2014 - 2:00PM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
Form 8-K
CURRENT
REPORT
Pursuant to
Section 13 or 15(d) of the Securities Exchange Act of 1934
Date
of Report: (Date of earliest event reported) April 9, 2014
Amfil
Technologies Inc.
(Exact
name of registrant as specified in its charter)
Commission
File Number: 33-2775-A
New York
|
13-3296819
|
(State or other jurisdiction
of incorporation)
|
(IRS Employer
Identification No.)
|
3601 Hwy. 7 Suite#400, Markham, Ontario, L3R 0M3 Canada
(Address
of principal executive offices, including zip code)
647
880-5887
(Registrant’s telephone number, including area code)
77
Davisville Ave., Suite 2317, Toronto, M4S 1G4. Ontario, Canada
(Former
Name or Former Address, if Changed Since Last Report)
Check the
appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any
of the following provisions:
⃞
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
⃞
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
⃞
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
⃞ Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
ITEM 1.01 ENTRY INTO A MATERIAL DEFINITIVE AGREEMENT
On April 8th, 2014, Mr. Roger Mortimer, the President and CEO
and Director of Amfil Technologies Inc., entered into a letter
agreement to enter into a Joint Venture Agreement to acquire a 50%
shared ownership with Antibacterial Cleaning Treatment Services Inc. (A.C.T.S.
Inc.) of the mPact -GROzone Antimicrobial Systems and
the exclusive right of representation to perform with A.C.T.S. Inc. as
a Systems and Service Provider to any Medical Marijuana Industry
and legal marijuana grow/process establishments or organizations in
North America and globally that is amenable to the use of the Systems
and Service of mPact -GROzone Antimicrobial Systems using A.C.T.S.
Inc.’s trade- marked and proprietary products and systems are
more particularly described in the attached exhibit.
ITEM 9.01 Financial Statements & Exhibits
(b)
Exhibits.
1. Letter of Intent between AMFIL
Technologies, Inc and A.C.T.S. Inc.
2. LOI
Agreement signatures
This Form 8-K may contain forward looking statements within the meaning
of Section 27A of the Securities Act of 1933, Section 21E of the
Securities Exchange Act of 1934 and Safe Harbor Statements under the
Private Securities Litigation Reform Act of 1995; The actual results
could differ materially from those set forth in the forward looking
statements that are subject to risks and uncertainties, including, but
not limited to, the impact of competitive products and pricing, product
demand and market acceptance, new product development, reliance on key
strategic alliances, availability of raw materials, the regulatory
environment, fluctuations in operating results, and other risks.
Signatures:
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorised.
|
|
Amfil Technologies Inc
|
|
|
|
|
|
|
April 9, 2014
|
By:
|
/s/ Larry Leverton
|
|
|
Larry Leverton
|
|
|
Secretary/Vice President & Director
|
|
|
|
EXHIBIT INDEX
Exhibit No.
|
Description
|
EX-1
|
Letter of Intent Agreement between AMFIL Technologies, Inc. and
A.C.T.S. Inc.
|
|
|
EX-2
|
Letter of Intent Agreement signatures
|
Amfil Technologies (PK) (USOTC:FUNN)
Historical Stock Chart
From Apr 2024 to May 2024
Amfil Technologies (PK) (USOTC:FUNN)
Historical Stock Chart
From May 2023 to May 2024